The behavioral economics of substance use disorders: reinforcement pathologies and their repair
- PMID: 24679180
- PMCID: PMC4501268
- DOI: 10.1146/annurev-clinpsy-032813-153724
The behavioral economics of substance use disorders: reinforcement pathologies and their repair
Abstract
The field of behavioral economics has made important inroads into the understanding of substance use disorders through the concept of reinforcer pathology. Reinforcer pathology refers to the joint effects of (a) the persistently high valuation of a reinforcer, broadly defined to include tangible commodities and experiences, and/or (b) the excessive preference for the immediate acquisition or consumption of a commodity despite long-term negative outcomes. From this perspective, reinforcer pathology results from the recursive interactions of endogenous person-level variables and exogenous environment-level factors. The current review describes the basic principles of behavioral economics that are central to reinforcer pathology, the processes that engender reinforcer pathology, and the approaches and procedures that can repair reinforcement pathologies. The overall goal of this review is to present a new understanding of substance use disorders as viewed by recent advances in behavioral economics.
Figures
References
-
- Acker J, Amlung M, Stojek M, Murphy JG, MacKillop J. Individual variation in behavioral economic indices of the relative value of alcohol: incremental validity in relation to impulsivity, craving, and intellectual functioning. J Exp Psychopathol. 2012;3:423–36.
-
- Alessi SM, Badger GJ, Higgins ST. An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp Clin Psychopharmacol. 2004;12:276–87. - PubMed
-
- Alessi SM, Petry NM. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Process. 2003;64:345–54. - PubMed
Publication types
MeSH terms
Grants and funding
- R01DA030241/DA/NIDA NIH HHS/United States
- R01DA034755/DA/NIDA NIH HHS/United States
- R01 DA032363/DA/NIDA NIH HHS/United States
- R01 DA034755/DA/NIDA NIH HHS/United States
- 1U19CA157345/CA/NCI NIH HHS/United States
- U19 CA157345/CA/NCI NIH HHS/United States
- R01DA024080/DA/NIDA NIH HHS/United States
- R21 DA032717/DA/NIDA NIH HHS/United States
- R01 AA021529/AA/NIAAA NIH HHS/United States
- R21DA032717/DA/NIDA NIH HHS/United States
- R01 DA024080/DA/NIDA NIH HHS/United States
- R01 DA030241/DA/NIDA NIH HHS/United States
- R01DA032363/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
